How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
Goligorsky
Michael S
MS
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use*; D050684:E2F Transcription Factors / Q000235:genetics / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000235:genetics / Q000503:physiopathology; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy*
D000970:Antineoplastic Agents; D050684:E2F Transcription Factors; D002945:Cisplatin